Standard of care treatments

OTHER2 trials

Sponsors

Ottawa Hospital Research Institute, RTOG Foundation, Inc.

Conditions

Breast CancerIntracranial Meningioma

Phase 2

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

RecruitingNCT06955169

RTOG Foundation, Inc.Intracranial Meningioma

Start: 2025-08-24End: 2030-08-01Target: 130Updated: 2026-09-08

Phase 4

Utilizing MyChart to Assess the Effectiveness of Interventions for Vasomotor Symptoms: A Feasibility Study

CompletedNCT05222464

Ottawa Hospital Research InstituteBreast Cancer

Start: 2022-02-25End: 2022-09-22Updated: 2025-12-18